Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
Wanbo Tai, Xiujuan Zhang, Aleksandra Drelich, et al.
Cell Research (2020) Vol. 30, Iss. 10, pp. 932-935
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner, Jane A. O’Halloran, Elizaveta Kalaidina, et al.
Nature (2021) Vol. 596, Iss. 7870, pp. 109-113
Open Access | Times Cited: 727
mRNA-based therapeutics: powerful and versatile tools to combat diseases
Shugang Qin, Xiaoshan Tang, Yu‐Ting Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 384
Lipids and Lipid Derivatives for RNA Delivery
Yuebao Zhang, Changzhen Sun, Chang Wang, et al.
Chemical Reviews (2021) Vol. 121, Iss. 20, pp. 12181-12277
Open Access | Times Cited: 381
Circular RNA vaccines against SARS-CoV-2 and emerging variants
Liang Qu, Zongyi Yi, Yong Shen, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1728-1744.e16
Open Access | Times Cited: 374
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
mRNA vaccine: a potential therapeutic strategy
Yang Wang, Ziqi Zhang, Jingwen Luo, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 298
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Katharine H. D. Crawford, Adam S. Dingens, Rachel Eguia, et al.
The Journal of Infectious Diseases (2020) Vol. 223, Iss. 2, pp. 197-205
Open Access | Times Cited: 263
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Emily Bettini, Michela Locci
Vaccines (2021) Vol. 9, Iss. 2, pp. 147-147
Open Access | Times Cited: 236
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao, Shan Zhao, Junxian Ou, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 212
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu, Wei Xu, Shuai Xia, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 190
Lipid Nanoparticles as Delivery Systems for RNA-Based Vaccines
Basmah N. Aldosari, Iman M. Alfagih, Alanood S. Almurshedi
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 206-206
Open Access | Times Cited: 170
A Single Immunization with Spike-Functionalized Ferritin Vaccines Elicits Neutralizing Antibody Responses against SARS-CoV-2 in Mice
Abigail E. Powell, Kaiming Zhang, Mrinmoy Sanyal, et al.
ACS Central Science (2021) Vol. 7, Iss. 1, pp. 183-199
Open Access | Times Cited: 169
Learning from the past: development of safe and effective COVID-19 vaccines
Shan Su, Lanying Du, Shibo Jiang
Nature Reviews Microbiology (2020) Vol. 19, Iss. 3, pp. 211-219
Open Access | Times Cited: 164
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 138
Scientific rationale for developing potent RBD-based vaccines targeting COVID-19
Harry Kleanthous, Judith M. Silverman, Karen W. Makar, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 136
mRNA Delivery of a Bispecific Single‐Domain Antibody to Polarize Tumor‐Associated Macrophages and Synergize Immunotherapy against Liver Malignancies
Ying Wang, Karthik Tiruthani, Sirui Li, et al.
Advanced Materials (2021) Vol. 33, Iss. 23
Open Access | Times Cited: 103
Circular RNA vaccine in disease prevention and treatment
Dun Niu, Yaran Wu, Jiqin Lian
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 75
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 54
Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus
Yaling Wang, Yuping Xie, Jia Luo, et al.
Nano Today (2021) Vol. 38, pp. 101139-101139
Open Access | Times Cited: 81
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles
Uri Elia, Srinivas Ramishetti, Ronit Rosenfeld, et al.
ACS Nano (2021) Vol. 15, Iss. 6, pp. 9627-9637
Closed Access | Times Cited: 79
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2
Qingrui Huang, Kai Ji, Siyu Tian, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 74
The self-assembled nanoparticle-based trimeric RBD mRNA vaccine elicits robust and durable protective immunity against SARS-CoV-2 in mice
Wenqiang Sun, Lihong He, He Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 65
Toward closed-loop drug delivery: Integrating wearable technologies with transdermal drug delivery systems
Jyothsna Manikkath, J. Anand Subramony
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 113997-113997
Closed Access | Times Cited: 61
Microarray patches enable the development of skin-targeted vaccines against COVID-19
Emrullah Korkmaz, Stephen C. Balmert, Tina L. Sumpter, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 164-186
Open Access | Times Cited: 55
mRNA vaccines: Past, present, future
Mia Karam, Georges Daoud
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 4, pp. 491-522
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top